Patients with p16INK4A-positive expression had significantly less lymph node metastasis (35.7 % versus 57.5 %) and were diagnosed at less advanced TNM stage, although the difference was not significant (p = 0.147). Here, CDKN2A is linked to metastatic malignant neoplasm in the lymph nodes.